Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Monsea Ltd.
With
Harmonium International Inc.
Pharma Agency
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
signed written informed consent
histologically proven colorectal cancer patients started new line of chemotherapy based on irinotecan
ECOG PS 0 - 1 at study entry
life expectancy more than 3 months
absence of any psychological, familial, sociological or geographical condition potentially hampering compliance with the study protocol and follow-up schedule;
You may not be if
impossibility to take oral medication
active infection treated by antibiotic therapy
ileostomy
hypersensitivity to study drug
any concurrent malignancy other than non-melanoma skin cancer, no other cancer in past 5 years.
serious concomitant systemic disorders or diseases incompatible with the study (at the discretion of investigator )
Clareo Health | Prevention of Irinotecan Induced Diarrhea by Probiotics
